Views & Analysis Digital Health Round-up: Teva looks to AI for drug repurposi... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Teva and IBM Watson team up for drug repurposing New three-year deal will use Watson to discover new indications for existing drugs.
News Teva buys US rights to Celltrion biosimilars Israeli firm buys rights to near-copies of Roche blockbusters.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
